ES2625636T3 - Proceso para preparar inhibidores del metabolismo de nucleósidos - Google Patents
Proceso para preparar inhibidores del metabolismo de nucleósidos Download PDFInfo
- Publication number
- ES2625636T3 ES2625636T3 ES09150953.9T ES09150953T ES2625636T3 ES 2625636 T3 ES2625636 T3 ES 2625636T3 ES 09150953 T ES09150953 T ES 09150953T ES 2625636 T3 ES2625636 T3 ES 2625636T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- pyrrolo
- pyrimidin
- amino
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 230000004060 metabolic process Effects 0.000 title 1
- 239000002777 nucleoside Substances 0.000 title 1
- 150000003833 nucleoside derivatives Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 7
- FFYPRJYSJODFFD-UHFFFAOYSA-N 2-amino-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one Chemical compound O=C1NC(N)=NC2=C1NC=C2 FFYPRJYSJODFFD-UHFFFAOYSA-N 0.000 abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- UWMXUDUWVFWJPX-UHFFFAOYSA-N 1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one Chemical compound OC1=NC=NC2=C1NC=C2 UWMXUDUWVFWJPX-UHFFFAOYSA-N 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/14—Pyrrolo-pyrimidine radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Compuesto de la fórmula:**Fórmula** en donde Y es un grupo alquilo o arilalquilo sustituido o no sustituido que tiene de 1 a 8 átomos de carbono.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ33509099 | 1999-04-08 | ||
| NZ33509099 | 1999-04-08 | ||
| NZ33616899 | 1999-06-08 | ||
| NZ33616899 | 1999-06-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2625636T3 true ES2625636T3 (es) | 2017-07-20 |
Family
ID=26652045
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES00917509T Expired - Lifetime ES2324016T3 (es) | 1999-04-08 | 2000-04-07 | Procedimiento para preparar inhibidores del metabolismo de nucleosidos. |
| ES09150953.9T Expired - Lifetime ES2625636T3 (es) | 1999-04-08 | 2000-04-07 | Proceso para preparar inhibidores del metabolismo de nucleósidos |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES00917509T Expired - Lifetime ES2324016T3 (es) | 1999-04-08 | 2000-04-07 | Procedimiento para preparar inhibidores del metabolismo de nucleosidos. |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US6693193B1 (es) |
| EP (2) | EP1165564B1 (es) |
| JP (2) | JP4430247B2 (es) |
| KR (1) | KR100755110B1 (es) |
| CN (2) | CN1196704C (es) |
| AT (1) | ATE425165T1 (es) |
| AU (1) | AU776540C (es) |
| CA (3) | CA2368095C (es) |
| CY (2) | CY1109103T1 (es) |
| DE (1) | DE60041757D1 (es) |
| DK (2) | DK2077268T5 (es) |
| ES (2) | ES2324016T3 (es) |
| LT (1) | LT2077268T (es) |
| NZ (1) | NZ514660A (es) |
| PT (2) | PT1165564E (es) |
| SI (2) | SI2077268T1 (es) |
| WO (1) | WO2000061783A2 (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985848A (en) * | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
| PT1165564E (pt) * | 1999-04-08 | 2009-04-16 | Einstein Coll Med | Processo para a preparação de inibidores do metabolismo de nucleósidos |
| WO2002018371A1 (en) * | 2000-08-29 | 2002-03-07 | Industrial Research Limited | Nucleoside metabolism inhibitors |
| US7098334B2 (en) * | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| US7553839B2 (en) | 2002-08-21 | 2009-06-30 | Industrial Research Limited | 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| NZ523970A (en) * | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
| US6972331B2 (en) | 2003-04-23 | 2005-12-06 | Biocryst Pharmaceuticals, Inc. | Carboxy pyrrole, process of preparing and use as precursor |
| US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
| NZ533360A (en) * | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| NZ540160A (en) * | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
| WO2007016291A2 (en) * | 2005-07-27 | 2007-02-08 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases |
| NZ544187A (en) | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
| WO2007097643A1 (en) * | 2006-02-22 | 2007-08-30 | Industrial Research Limited | Analogues of coformycin and their use for treating protozoan parasite infections |
| WO2007097647A1 (en) * | 2006-02-24 | 2007-08-30 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer |
| JP2009528996A (ja) * | 2006-02-24 | 2009-08-13 | インダストリアル リサーチ リミテッド | ヌクレオシドホスホリラーゼ及びヌクレオシダーゼの阻害剤を用いて疾患を処置する方法 |
| CN101094080B (zh) * | 2006-06-22 | 2012-06-20 | 华为技术有限公司 | 一种即按即通系统中的计费方法 |
| US8383636B2 (en) * | 2006-09-07 | 2013-02-26 | Industrial Research Limited | Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase |
| ES2362805T3 (es) | 2006-09-07 | 2011-07-13 | Industrial Research Limited | Inhibidores aminoacíclicos de nucleósido fosforilasas e hidrolasas. |
| DK2114925T3 (da) * | 2006-12-22 | 2012-05-29 | Ind Res Ltd | Azetidin-analoger af nucleosidase- og phosphorylase-inhibitorer |
| WO2009132050A2 (en) | 2008-04-21 | 2009-10-29 | Otonomy, Inc. | Auris formulations for treating otic diseases and conditions |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| US8784870B2 (en) | 2008-07-21 | 2014-07-22 | Otonomy, Inc. | Controlled release compositions for modulating free-radical induced damage and methods of use thereof |
| WO2010033236A2 (en) * | 2008-09-22 | 2010-03-25 | Albert Einstein College Of Medicine Of Yeshiva University | Methods and compositions for treating bacterial infections by inhibiting quorum sensing |
| JP5861243B2 (ja) | 2009-07-17 | 2016-02-16 | アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ | ５’−メチルチオアデノシンホスホリラーゼ及びヌクレオシダーゼの３−ヒドロキシピロリジン阻害剤 |
| US9290501B2 (en) | 2010-11-29 | 2016-03-22 | Albert Einstein College Of Medicine, Inc. | Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase |
| CN103391777A (zh) | 2011-02-02 | 2013-11-13 | 普林斯顿大学理事会 | 作为病毒产生调节剂的去乙酰化酶调节剂 |
| WO2013149258A2 (en) | 2012-03-30 | 2013-10-03 | Charles Drew University of Medicine and Science | Compositions and methods for treating or preventing metabolic syndrome disorders |
| AR090699A1 (es) * | 2012-04-18 | 2014-12-03 | Biocryst Pharm Inc | Compuestos inhibidores de la actividad de la arn polimerasa viral |
| EP3478269A4 (en) | 2016-06-29 | 2020-04-08 | Otonomy, Inc. | OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES |
| US11114184B2 (en) | 2017-02-21 | 2021-09-07 | Albert Einstein College Of Medicine | DNA methyltransferase 1 transition state structure and uses thereof |
| CN110590786B (zh) * | 2019-09-29 | 2021-12-03 | 上海大学 | 9-去氮鸟嘌呤合成工艺的改进方法 |
| CN111704619B (zh) | 2020-07-30 | 2021-10-19 | 四川大学 | 一种Forodesine的制备方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE157607T1 (de) * | 1992-11-06 | 1997-09-15 | Ulrich Rindlisbacher | Vorrichtung zum befestigen an einem gestell eines zweiradfahrzeugs |
| IL107616A0 (en) | 1992-11-18 | 1994-02-27 | Univ Johns Hopkins | Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers which comprise pyrimidine analogs |
| US6379911B2 (en) | 1996-02-23 | 2002-04-30 | Albert Einstein College Of Medicine Of Yeshiva University | Enzyme detection/assay method and substrates |
| US5985848A (en) * | 1997-10-14 | 1999-11-16 | Albert Einstein College Of Medicine Of Yeshiva University | Inhibitors of nucleoside metabolism |
| US6187777B1 (en) * | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
| PT1165564E (pt) * | 1999-04-08 | 2009-04-16 | Einstein Coll Med | Processo para a preparação de inibidores do metabolismo de nucleósidos |
| US6448799B1 (en) * | 1999-09-30 | 2002-09-10 | Hitachi Electronics Engineering Co., Ltd. | Timing adjustment method and apparatus for semiconductor IC tester |
| WO2002018371A1 (en) | 2000-08-29 | 2002-03-07 | Industrial Research Limited | Nucleoside metabolism inhibitors |
| US6458799B1 (en) | 2000-08-31 | 2002-10-01 | Biocryst Pharmaceuticals, Inc. | Deazaguanine analog, preparation thereof and use thereof |
| US7098334B2 (en) | 2002-03-25 | 2006-08-29 | Industrial Research Limited | 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| US7553839B2 (en) | 2002-08-21 | 2009-06-30 | Industrial Research Limited | 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| NZ523970A (en) | 2003-02-04 | 2005-02-25 | Ind Res Ltd | Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases |
| NZ533360A (en) | 2004-06-04 | 2007-02-23 | Ind Res Ltd | Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| WO2006014913A2 (en) | 2004-07-27 | 2006-02-09 | Biocryst Pharmaceuticals, Inc. | Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
| NZ540160A (en) | 2005-05-20 | 2008-03-28 | Einstein Coll Med | Inhibitors of nucleoside phosphorylases |
| NZ544187A (en) | 2005-12-15 | 2008-07-31 | Ind Res Ltd | Deazapurine analogs of 1'-aza-l-nucleosides |
| JP2009528996A (ja) | 2006-02-24 | 2009-08-13 | インダストリアル リサーチ リミテッド | ヌクレオシドホスホリラーゼ及びヌクレオシダーゼの阻害剤を用いて疾患を処置する方法 |
| WO2007097647A1 (en) | 2006-02-24 | 2007-08-30 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of treating cancer |
-
2000
- 2000-04-07 PT PT00917509T patent/PT1165564E/pt unknown
- 2000-04-07 CA CA002368095A patent/CA2368095C/en not_active Expired - Lifetime
- 2000-04-07 ES ES00917509T patent/ES2324016T3/es not_active Expired - Lifetime
- 2000-04-07 NZ NZ514660A patent/NZ514660A/en not_active IP Right Cessation
- 2000-04-07 CN CNB008084416A patent/CN1196704C/zh not_active Expired - Lifetime
- 2000-04-07 LT LTEP09150953.9T patent/LT2077268T/lt unknown
- 2000-04-07 AT AT00917509T patent/ATE425165T1/de active
- 2000-04-07 SI SI200031091A patent/SI2077268T1/sl unknown
- 2000-04-07 EP EP00917509A patent/EP1165564B1/en not_active Expired - Lifetime
- 2000-04-07 ES ES09150953.9T patent/ES2625636T3/es not_active Expired - Lifetime
- 2000-04-07 PT PT91509539T patent/PT2077268T/pt unknown
- 2000-04-07 CN CN2006101484657A patent/CN101062928B/zh not_active Expired - Lifetime
- 2000-04-07 CA CA2696826A patent/CA2696826C/en not_active Expired - Lifetime
- 2000-04-07 DK DK09150953.9T patent/DK2077268T5/en active
- 2000-04-07 DK DK00917509T patent/DK1165564T3/da active
- 2000-04-07 KR KR1020017012816A patent/KR100755110B1/ko not_active Expired - Lifetime
- 2000-04-07 AU AU38469/00A patent/AU776540C/en not_active Expired
- 2000-04-07 WO PCT/NZ2000/000048 patent/WO2000061783A2/en not_active Ceased
- 2000-04-07 EP EP09150953.9A patent/EP2077268B1/en not_active Expired - Lifetime
- 2000-04-07 DE DE60041757T patent/DE60041757D1/de not_active Expired - Lifetime
- 2000-04-07 JP JP2000611706A patent/JP4430247B2/ja not_active Expired - Lifetime
- 2000-04-07 CA CA2634299A patent/CA2634299C/en not_active Expired - Lifetime
- 2000-04-07 US US09/958,219 patent/US6693193B1/en not_active Expired - Lifetime
- 2000-04-07 SI SI200031026T patent/SI1165564T1/sl unknown
-
2003
- 2003-12-16 US US10/737,724 patent/US7022852B2/en not_active Expired - Lifetime
-
2005
- 2005-12-08 US US11/297,954 patent/US7211677B2/en not_active Expired - Lifetime
-
2007
- 2007-03-09 US US11/716,100 patent/US7405297B2/en not_active Expired - Lifetime
-
2009
- 2009-03-30 JP JP2009080777A patent/JP5070237B2/ja not_active Expired - Lifetime
- 2009-05-28 CY CY20091100568T patent/CY1109103T1/el unknown
-
2017
- 2017-05-31 CY CY20171100563T patent/CY1119099T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1165564T3 (da) | Fremgangsmåde til fremstilling af inhibitorer af nukleosidmetabolisme | |
| MY145298A (en) | Chemical process | |
| ATE255110T1 (de) | Fungizide 7-alkyl-triazolopyrimidine | |
| EP1690861A3 (en) | A process for preparing duloxetine and intermediates for use therein | |
| BRPI0414059A (pt) | sìntese seletiva de pirimidinas substituìdas em cf3 | |
| ES2159488A1 (es) | Procedimiento para la preparacion de derivados de pirimidona con actividad antifugica. | |
| BR9812524A (pt) | Processos e intermediários utilizáveis para produzir antifolatos | |
| DK1272477T3 (da) | Pyrimidinforbindelser | |
| MXPA05008183A (es) | Proceso para preparar pirrolotriazina como inhibidores de cinasa. | |
| NZ505103A (en) | Phenylaminoalkylcarboxylic acid derivatives useful as beta 3 adrenoceptor stimulants | |
| CA2339250A1 (en) | Synthesis of acyclic nucleoside derivatives | |
| RU2007112108A (ru) | Производные пирроло[3, 2-с]пиридина и способ их получения | |
| ES8704486A1 (es) | Procedimiento de preparar derivados rodaninicos. | |
| BR0009453B1 (pt) | processo para a preparação de um composto. | |
| IL133814A0 (en) | Process for the preparation of 1-aryl-3-cyclopropyl-1, 3-propanediones | |
| PT1210359E (pt) | Processo para a preparacao de derivados do acido 3-amino-biliar | |
| NO932709D0 (no) | 2-substituerte chinolylmetoksy-fenyleddiksyrederivater | |
| AR030571A1 (es) | Proceso para preparar 2-(-piridin-4-ilamino)-pirido[2,3-d] pirimidinas e intermediarios en su sintesis | |
| DK0798297T3 (da) | Fremgangsmåde til fremstilling af 2-alkoxy-6-(trifluormethyl)-pyrimidin-4-ol | |
| SE0101323D0 (sv) | New process | |
| ES2138535A1 (es) | Procedimiento para la preparacion de los compuestos antivirales penciclovir y famciclovir. | |
| BR9810687B1 (pt) | processo para a preparação de um composto derivado de 2-alquiltiobenzonitrila. | |
| MXPA01008189A (es) | Proceso para la preparacion de compuestos 6-)perfluoroalquil) uracilo a partir de compuestos de urea. | |
| ZA99614B (en) | Process for the preparation of S-alkylcysteines. | |
| BR0308297A (pt) | Processo para a preparação de um composto |